Back to Search
Start Over
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
- Source :
- Le Gouill , S , Długosz-Danecka , M , Rule , S , Zinzani , P L , Goy , A , Smith , S D , Doorduijn , J K , Panizo , C , Shah , B D , Davies , A J , Eek , R , Jacobsen , E , Kater , A P , Robak , T , Jain , P , Calvo , R , Tao , L & Wang , M 2024 , ' Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors ' , Haematologica , vol. 109 , no. 1 , pp. 343-350 .
- Publication Year :
- 2024
Details
- Database :
- OAIster
- Journal :
- Le Gouill , S , Długosz-Danecka , M , Rule , S , Zinzani , P L , Goy , A , Smith , S D , Doorduijn , J K , Panizo , C , Shah , B D , Davies , A J , Eek , R , Jacobsen , E , Kater , A P , Robak , T , Jain , P , Calvo , R , Tao , L & Wang , M 2024 , ' Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors ' , Haematologica , vol. 109 , no. 1 , pp. 343-350 .
- Notes :
- application/pdf, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1417973168
- Document Type :
- Electronic Resource